Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase

被引:213
作者
Shewchuk, L [1 ]
Hassell, A [1 ]
Wisely, B [1 ]
Rocque, W [1 ]
Holmes, W [1 ]
Veal, J [1 ]
Kuyper, LF [1 ]
机构
[1] Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/jm990401t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
4-Anilinoquinazolines represent an important class of protein kinase inhibitor. Modes of binding for two members of this inhibitor class were determined by X-ray crystallographic analysis of one inhibitor(4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline)in complex with cyclin-dependent kinase 2 (CDK2) and the other (4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline) in complex with p38 kinase. In both inhibitor/kinase structures, the 4-anilinoquinazoline was bound in the ATP site with the quinazoline ring system oriented along the peptide strand that links the two domains of the protein and with the anilino substituent projecting into a hydrophobic pocket within the protein interior. In each case, the nitrogen at position-1 of the quinazoline accepted a hydrogen bond from a backbone NH (CDK2, Leu-83; p38, Met-109) of the domain connector strand, and aromatic hydrogen atoms at C2 and C8 interacted with backbone carbonyl oxygen atoms of the peptide strand. The anilino group of the CDK2-bound compound was essentially coplanar with the quinazoline ring system and occupied a pocket between Lys-33 and Phe-80. For the p38-bound inhibitor, the anilino group was angled out of plane and was positioned between Lys-53 and Thr-106 in a manner similar to that observed for the aryl substituent of the pyridinylimidazole class of inhibitor.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 49 条
  • [1] Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96
  • [2] METHOXY GROUP NONPLANARITY IN OMICRON-DIMETHOXYBENZENES - SIMPLE PREDICTIVE MODELS FOR CONFORMATIONS AND ROTATIONAL BARRIERS IN ALKOXYAROMATICS
    ANDERSON, GM
    KOLLMAN, PA
    DOMELSMITH, LN
    HOUK, KN
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1979, 101 (09) : 2344 - 2352
  • [3] Crystal structure and mutational analysis the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1
    Bourne, Y
    Watson, MH
    Hickey, MJ
    Holmes, W
    Rocque, W
    Reed, SI
    Tainer, JA
    [J]. CELL, 1996, 84 (06) : 863 - 874
  • [4] Tyrosine kinase inhibitors .8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor
    Bridges, AJ
    Zhou, H
    Cody, DR
    Rewcastle, GW
    McMichael, A
    Showalter, HDH
    Fry, DW
    Kraker, AJ
    Denny, WA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 267 - 276
  • [5] FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES
    BRUNGER, AT
    [J]. NATURE, 1992, 355 (6359) : 472 - 475
  • [6] Brunger AT, 1992, XPLOR VERSION 3 1 MA
  • [7] BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125
  • [8] Inhibition of cyclin-dependent kinases by purine analogues - Crystal structure of human cdk2 complexed with roscovitine
    DeAzevedo, WF
    Leclerc, S
    Meijer, L
    Havlicek, L
    Strnad, M
    Kim, SH
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2): : 518 - 526
  • [9] Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase
    deAzevedo, WF
    MuellerDieckmann, HJ
    SchulzeGahmen, U
    Worland, PJ
    Sausville, E
    Kim, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) : 2735 - 2740
  • [10] CRYSTAL-STRUCTURE OF CYCLIN-DEPENDENT KINASE-2
    DEBONDT, HL
    ROSENBLATT, J
    JANCARIK, J
    JONES, HD
    MORGAN, DO
    KIM, SH
    [J]. NATURE, 1993, 363 (6430) : 595 - 602